Evaluation of renal biopsy samples of patients with diabetic nephropathy

被引:43
作者
Suzuki, D [1 ]
Takano, H [1 ]
Toyoda, M [1 ]
Umezono, T [1 ]
Uehara, G [1 ]
Sakai, T [1 ]
Zhang, SY [1 ]
Mori, Y [1 ]
Yagame, M [1 ]
Endoh, M [1 ]
Sakai, H [1 ]
机构
[1] Tokai Univ, Sch Med, Dept Internal Med, Div Nephrol & Metab, Isehara, Kanagawa 2591193, Japan
关键词
mesangial expansion; tubulointerstitial injury; glomerulosclerosis;
D O I
10.2169/internalmedicine.40.1077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To evaluate the usefulness of renal biopsy in the overall management of patients with diabetes mellitus (DM), we examined the relationship between the clinical parameters and histopathological findings of renal biopsy samples. Methods Renal biopsy specimens were obtained from 109 type 2 diabetic patients with proteinuria. Samples were divided into the following two groups: Diabetic Nephropathy (DN) group (n=80) had typical diabetic lesions without other renal diseases, complication group (n=29) had diabetic lesions with other renal diseases. Furthermore, DN group was subdivided into two subgroups: slow progressive group (SP group, n=32), the level of serum creatinine (s-Cr) was normal at the time of renal biopsy and three years after renal biopsy, and fast progressive group (Fl? group, n=14), the level of s-Cr was normal at the time of renal biopsy but more than doubled three years after renal biopsy. Results The level of total protein was significantly lower and HbA1c significantly higher in the DN group than in the Complication group. However, other clinical parameters were not significantly different between the two groups. Urinary protein, systolic and diastolic blood pressure in FP group were significantly higher than in SP group. The percentage of sclerotic glomeruli, the severity of mesangial expansion, tubular injury and cell infiltration were significantly greater in FP than in SP group. Conclusions Our results indicated that a complete evaluation of renal pathology in DM could not be made by clinical parameters only, and that the progression of DN could be accurately predicted by histopathological evaluation. Therefore, this study emphasizes the importance of renal biopsy in the overall management of patients with DM and/ or DN.
引用
收藏
页码:1077 / 1084
页数:8
相关论文
共 34 条
[1]   GROWTH-FACTORS IN GLOMERULONEPHRITIS [J].
ABBOUD, HE ;
SCHENA, FP ;
COHEN, JJ ;
STERZEL, RB ;
STRIKER, G ;
GESUALDO, L ;
FINE, LG ;
STRIKER, L ;
PETEN, E ;
THOMSON, N ;
CAMERON, S ;
BORSATTI, A ;
RUBINKELLY, VE ;
REMUZZI, G .
KIDNEY INTERNATIONAL, 1993, 43 (01) :252-267
[2]  
Abboud HE, 1997, KIDNEY INT, pS3
[3]   THE EFFECT OF OXIDATION ON SORBITOL PATHWAY KINETICS [J].
BARNETT, PA ;
GONZALEZ, RG ;
CHYLACK, LT ;
CHENG, HM .
DIABETES, 1986, 35 (04) :426-432
[4]  
BOHLE A, 1991, PATHOL RES PRACT, V187, P251
[5]  
Brenner B M, 1990, Adv Nephrol Necker Hosp, V19, P135
[6]  
BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
[7]   Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria [J].
Chaturvedi, N ;
Stevenson, J ;
Fuller, JH ;
Rottiers, R ;
Ferriss, B ;
Karamanos, B ;
Kofinis, A ;
Petrou, C ;
IonescuTirgovisite, C ;
Iosif, C ;
Tamas, G ;
Bibok, G ;
Kerenyi, Z ;
KisGombos, P ;
Toth, J ;
Grealy, G ;
Priem, H ;
Koivisto, V ;
Tuominen, J ;
Kostamo, E ;
IdziorWalus, B ;
Solnica, B ;
GalickaLatalie, D ;
Michel, G ;
Keipes, M ;
Giuliani, A ;
Herode, A ;
Santeusanio, F ;
Bueti, A ;
Bistoni, S ;
Cagini ;
Navalesi, R ;
Penno, G ;
Nannipieri, M ;
Rizzo, L ;
Miccoli, R ;
Ghirlanda, G ;
Cotroneo, P ;
Manto, A ;
Minella, A ;
Saponara, C ;
Ward, J ;
Plater, M ;
Ibrahim, S ;
Ibbotson, S ;
Mody, C ;
Papazoglou, N ;
Manes, C ;
Soulis, K ;
Voukias, M .
LANCET, 1997, 349 (9068) :1787-1792
[8]  
DAVISON AM, 1998, OXFORD TXB CLIN NEPH, P161
[9]  
Estacio RO, 2000, DIABETES CARE, V23, pB54
[10]  
GAMBARA V, 1993, J AM SOC NEPHROL, V3, P1458